LBEL EFFET PARFAIT Spots Reducing Effect Foundation SPF 18 - MEDIUM 5

Manufacturer: Ventura International, LTD | Bel Star S.A.
Effective date: 2012-03-24
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: legacy-cache
Hydrated at: 2026-08-02 01:47:47

Label at a glance#

ProductLBEL EFFET PARFAIT Spots Reducing Effect Foundation SPF 18 - MEDIUM 5

Active ingredientOCTINOXATE, OXYBENZONE

Label structure10 sections

Indications and uses

Helps prevent sunburn.

Dosage and administration

Apply liberally and evenly 15 minutes before sun exposure. Reapply at least every 2 hours Use a water resistant sunscreen if swimming or sweating. Children under 6 months of age: Ask a doctor.

Contacts and useful links#

Websitewww.lbel.com

www.lbel.com

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Octinoxate (7.5%), Oxybenzone (2.0%)

Uses

INDICATIONS & USAGE SECTION

Helps prevent sunburn.

Warnings

WARNINGS SECTION

Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
For external use only.

Do not use

OTC - DO NOT USE SECTION

on damaged or broken skin.

When using this product

OTC - WHEN USING SECTION

keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor

OTC - STOP USE SECTION

if rash occurs.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply liberally and evenly 15 minutes before sun exposure.
Reapply at least every 2 hours
Use a water resistant sunscreen if swimming or sweating.
Children under 6 months of age: Ask a doctor.

Other Information

SPL UNCLASSIFIED SECTION

Protect the product in this container from excessive heat and direct sun.
Apply using the sponge and cover the face evenly. Blend softly with the applicator or, if you prefer, your fingertips.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Isostearyl Neopentanoate, Mica, C12-15 Alkyl Benzoate, Ethylhexyl Palmitate, Polymethyl Methacrylate, Dimethicone/Vinyl Dimethicone Crosspolymer, Ozokerite, Kaolin, Polyethylene, Copernicia Cerifera Cera (Copernicia Cerifera (Carnauba) Wax), Zea Mays Starch (Zea Mays (Corn) Starch), Kojic Dipalmitate, Phenoxyethanol, Dimethicone, Octyldodecanol, Glyceryl Isostearate, Isostearyl Alcohol, Methylparaben, Silica, Butyrospermum Parkii Butter (Butyrospermum Parkii (Shea) Butter), Microcristallina Cera (Microcrystalline Wax), Propylparaben, Beta-Sitosterol, Parfum (Fragrance), Candelilla Cera (Euphorbia Cerifera (Candelilla) Wax), Trimethylsiloxysilicate, Petrolatum, Phospholipids, Bht, Glycyrrhiza Glabra Root Extract (Glycyrrhiza Glabra (Licorice) Root Extract), Butylparaben, Ethylparaben, Cholesterol, Isobutylparaben, Cera Alba (Beeswax), Cetearyl Alcohol, Cetearyl Glucoside, Polyglyceryl-2 Dipolyhydroxystearate, Glycosphingolipids.
May Contain: Ci 77891 (Titanium Dioxide), Ci 77492 (Iron Oxides), Ci 77491 (Iron Oxides), Ci 77499 (Iron Oxides), Chitosan

Purpose

OTC - PURPOSE SECTION

Sunscreen

EFFET PARFAIT

SPL UNCLASSIFIED SECTION

Facial Perfecting Line
L'BEL presents its Effet Parfait line to maximize your skin's beauty. An innovative line of perfecting makeup that adds luminosity to the face and gives it a youthful appearance thanks to the latest concept in cosmetic technology: Perfecting Technology. Effet Parfait products transform the appearance of your face, returning the healthy look and glow of youth. In addition to concealing and correcting imperfections, they prepare your skin for applying makeup shades and express your skin's maximum beauty and splendor.
spot reducing effect foundation SPF 18
A foundation with coverage that adapts to the needs of your face. With continual use, its innovative Photo Bright Complex technology helps diminish existing spots and, thanks to its photoadjustable pigments, evens out skin tone and conceals dark areas and surfaces more effectively, minimizing the intensity o spots and imperfections immediately.
The result: uniform, natural and youthful skin.
•    Covers spots and imperfections
•    Evens out skin tone.
•    Helps diminish existing spots.

USES: Helps prevent sunburn.

WARNINGS: Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging. For external use only. Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS:

•    Use in the morning after cleansing and toning. Apply small amounts using the fingertips and spreading with upward, circular movements. Rub gently until absorbed completely.
•    Apply liberally and evenly 15 minutes before sun exposure.
•    Reapply at least every 2 years
•    Use a water resistant sunscreen if swimming or sweating.
•    Children under 6 months of age: Ask a doctor.
Other Information:

•    Protect the product int his container from excessive heat and direct sun.
•    Apply using the sponge and cover the face evenly. Blend softly with the applicator or, if you prefer, your fingertips.
Effet Parfait features a line of products with benefits that complement one another. Follow this routine to attain perfect skin:

Step 1: Apply the Perfect Face Effect Retexturizing Gel.
Step 2: Apply the Effet Parfait foundation that best meets your skin's needs.
Step 3: Apply the Rejuvenating Effect Concealer.
Step 4: Apply the Effet Parfait Compact Powder that best meets y our skin's needs

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

L'BEL EFFET PARFAIT spot reducing effect foundation SPF 18 8g (.28 oz)

www.lbel.com P.R. : Distributed by Ventura Corporation, Ltd., San Juan, Puerto Rico 00926. US: Distributed by Ventura International Ltd., DBA Belcorp USA, San Francisco, CA 94111. Made in Colombia

L'BEL EFFET PARFAIT Spots Reducing Effect Foundation SPF 18 - MEDIUM 5 8g

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Effet Parfai 8g A

Effet Parfait 8g B

Effet Parfait 8g C

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
43455-0011-0	2025-03-31	C162847	48780-1	97449f38-c85a-f6ea-e053-dbdaa90aa703	L'BEL EFFET PARFAIT Spots Reducing Effect Foundation SPF 18 - MEDIUM 5
43455-0011-0	2019-11-13	C162847	48780-1	97449f38-c85a-f6ea-e053-dbdaa90aa703	L'BEL EFFET PARFAIT Spots Reducing Effect Foundation SPF 18 - MEDIUM 5

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	2
OXYBENZONE	ACTIVE INGREDIENT	95OOS7VE0Y	2
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	2
OXYBENZONE	ACTIVE MOIETY	95OOS7VE0Y	2
.BETA.-SITOSTEROL	INACTIVE INGREDIENT	S347WMO6M4	2
ALKYL (C12-15) BENZOATE	INACTIVE INGREDIENT	A9EJ3J61HQ	2
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	2
BUTYLPARABEN	INACTIVE INGREDIENT	3QPI1U3FV8	2
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	2
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	2
CERESIN	INACTIVE INGREDIENT	Q1LS2UJO3A	2
CETEARYL GLUCOSIDE	INACTIVE INGREDIENT	09FUA47KNA	2
CETOSTEARYL ALCOHOL	INACTIVE INGREDIENT	2DMT128M1S	2
CHOLESTEROL	INACTIVE INGREDIENT	97C5T2UQ7J	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	2
ETHYLHEXYL PALMITATE	INACTIVE INGREDIENT	2865993309	2
ETHYLPARABEN	INACTIVE INGREDIENT	14255EXE39	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	2
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	2
GLYCERYL ISOSTEARATE	INACTIVE INGREDIENT	HYE7O27HAO	2
GLYCYRRHIZA GLABRA	INACTIVE INGREDIENT	2788Z9758H	2
HIGH DENSITY POLYETHYLENE	INACTIVE INGREDIENT	UG00KM4WR7	2
ISOBUTYLPARABEN	INACTIVE INGREDIENT	0QQJ25X58G	2
ISOSTEARYL ALCOHOL	INACTIVE INGREDIENT	Q613OCQ44Y	2
ISOSTEARYL NEOPENTANOATE	INACTIVE INGREDIENT	411THY156Q	2
KAOLIN	INACTIVE INGREDIENT	24H4NWX5CO	2
KOJIC DIPALMITATE	INACTIVE INGREDIENT	13N249RWTM	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	2
MICA	INACTIVE INGREDIENT	V8A1AW0880	2
MICROCRYSTALLINE WAX	INACTIVE INGREDIENT	XOF597Q3KY	2
OCTYLDODECANOL	INACTIVE INGREDIENT	461N1O614Y	2
PETROLATUM	INACTIVE INGREDIENT	4T6H12BN9U	2
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	2
SHEA BUTTER	INACTIVE INGREDIENT	K49155WL9Y	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	2
TRIMETHYLSILOXYSILICATE (M/Q 0.66)	INACTIVE INGREDIENT	5041RX63GN	2
WHITE WAX	INACTIVE INGREDIENT	7G1J5DA97F	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 41 matching rows.

LBEL EFFET PARFAIT Spots Reducing Effect Foundation SPF 18 - MEDIUM 5
OCTINOXATE, OXYBENZONE
OCTINOXATE
OXYBENZONE
ISOSTEARYL NEOPENTANOATE
MICA
ALKYL (C12-15) BENZOATE
ETHYLHEXYL PALMITATE
DIMETHICONE
CERESIN
KAOLIN
HIGH DENSITY POLYETHYLENE
CARNAUBA WAX
STARCH, CORN
KOJIC DIPALMITATE
PHENOXYETHANOL
OCTYLDODECANOL
GLYCERYL ISOSTEARATE
ISOSTEARYL ALCOHOL
METHYLPARABEN
SILICON DIOXIDE
SHEA BUTTER
MICROCRYSTALLINE WAX
PROPYLPARABEN
.BETA.-SITOSTEROL
CANDELILLA WAX
TRIMETHYLSILOXYSILICATE (M/Q 0.66)
PETROLATUM
BUTYLATED HYDROXYTOLUENE
GLYCYRRHIZA GLABRA
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
ISOBUTYLPARABEN
WHITE WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
TITANIUM DIOXIDE
FERRIC OXIDE YELLOW
FERRIC OXIDE RED

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
43455-0011	43455-0011-0

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 39 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
OCTINOXATE	4Y5P7MUD51	ACTIB
OXYBENZONE	95OOS7VE0Y	ACTIB
ISOSTEARYL NEOPENTANOATE	411THY156Q	IACT
MICA	V8A1AW0880	IACT
ALKYL (C12-15) BENZOATE	A9EJ3J61HQ	IACT
ETHYLHEXYL PALMITATE	2865993309	IACT
DIMETHICONE	92RU3N3Y1O	IACT
CERESIN	Q1LS2UJO3A	IACT
KAOLIN	24H4NWX5CO	IACT
HIGH DENSITY POLYETHYLENE	UG00KM4WR7	IACT
CARNAUBA WAX	R12CBM0EIZ	IACT
STARCH, CORN	O8232NY3SJ	IACT
KOJIC DIPALMITATE	13N249RWTM	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
OCTYLDODECANOL	461N1O614Y	IACT
GLYCERYL ISOSTEARATE	HYE7O27HAO	IACT
ISOSTEARYL ALCOHOL	Q613OCQ44Y	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
SHEA BUTTER	K49155WL9Y	IACT
MICROCRYSTALLINE WAX	XOF597Q3KY	IACT
PROPYLPARABEN	Z8IX2SC1OH	IACT
.BETA.-SITOSTEROL	S347WMO6M4	IACT
CANDELILLA WAX	WL0328HX19	IACT
TRIMETHYLSILOXYSILICATE (M/Q 0.66)	5041RX63GN	IACT
PETROLATUM	4T6H12BN9U	IACT
BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	IACT
GLYCYRRHIZA GLABRA	2788Z9758H	IACT
BUTYLPARABEN	3QPI1U3FV8	IACT
ETHYLPARABEN	14255EXE39	IACT
CHOLESTEROL	97C5T2UQ7J	IACT
ISOBUTYLPARABEN	0QQJ25X58G	IACT
WHITE WAX	7G1J5DA97F	IACT
CETOSTEARYL ALCOHOL	2DMT128M1S	IACT
CETEARYL GLUCOSIDE	09FUA47KNA	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
FERRIC OXIDE YELLOW	EX438O2MRT	IACT
FERRIC OXIDE RED	1K09F3G675	IACT
FERROSOFERRIC OXIDE	XM0M87F357	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 9 · 485 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	TABLET, COATED / ORAL	0.08 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	JELLY / NASAL	250 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / IRRIGATION	2 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	TABLET, DELAYED RELEASE / ORAL	0.08 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	DROPS / OPHTHALMIC	0.01 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	JELLY / NASAL	140 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	CREAM, AUGMENTED / TOPICAL		2 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	SUSPENSION / ORAL		12 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION, SOLUTION / INTRAMUSCULAR		5 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SYSTEM / TOPICAL		21 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	FILM, SOLUBLE / ORAL		2 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	INSERT / VAGINAL		8 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	OINTMENT / TOPICAL		7275 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	LOTION / TOPICAL	25 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 32 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / ORAL		388 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
OCTYLDODECANOL	OCTYLDODECANOL	461N1O614Y	FILM, EXTENDED RELEASE / TRANSDERMAL	253.4 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, COATED / ORAL		49 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	TABLET / ORAL	5 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	OINTMENT / TOPICAL		2100 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / SUBCUTANEOUS		22 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	JELLY / TOPICAL		180 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, EXTENDED RELEASE / ORAL		90 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		69 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	CAPSULE / ORAL		1 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / SUBLINGUAL		10 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	OINTMENT, AUGMENTED / TOPICAL	81.94 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SHAMPOO, SUSPENSION / TOPICAL	0.15 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	POWDER / ORAL	NA		Exact identifier — unii candidate 79 equally ranked IID candidates
CARNAUBA WAX	CARNAUBA WAX	R12CBM0EIZ	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	140 mg		Exact identifier — unii candidate 11 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	CAPSULE, EXTENDED RELEASE / ORAL	0.03 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION / RECTAL	0.02 %w/v		Exact identifier — unii candidate 68 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	SUSPENSION / ORAL		6 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
CERESIN	CERESIN	Q1LS2UJO3A	CREAM / VAGINAL		280 mg	Exact identifier — unii candidate 2 equally ranked IID candidates
OCTYLDODECANOL	OCTYLDODECANOL	461N1O614Y	SUSPENSION / TOPICAL	2.01 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	OINTMENT / AURICULAR (OTIC)	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 79 equally ranked IID candidates
SHEA BUTTER	SHEA BUTTER	K49155WL9Y	LOTION / TOPICAL		2340 mg	Exact identifier — unii candidate
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	CREAM / VAGINAL		3 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION, SOLUTION / INTRAVENOUS		45 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	DROPS / ORAL	NA		Exact identifier — unii candidate 40 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	FILM, EXTENDED RELEASE / TRANSDERMAL	49 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		42 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	TABLET, FILM COATED / ORAL	0.2 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	CAPSULE / ORAL	NA		Exact identifier — unii candidate 15 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	CAPSULE, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 15 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, CHEWABLE / ORAL		2 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	POWDER, FOR SUSPENSION / ORAL	NA		Exact identifier — unii candidate 10 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	POWDER, FOR SUSPENSION / ORAL		297 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	SOLUTION / OPHTHALMIC	0.02 %w/w		Exact identifier — unii candidate 15 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	POWDER, FOR SOLUTION / ORAL		13 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	TABLET, EXTENDED RELEASE / ORAL	0.12 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	OINTMENT / TOPICAL		57 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	OINTMENT / OPHTHALMIC	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	PASTE, DENTIFRICE / DENTAL	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
STARCH, CORN	STARCH, CORN	O8232NY3SJ	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 22 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / SUBCUTANEOUS	0.16 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	POWDER / ORAL	NA		Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	ENEMA / RECTAL	0.02 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
fc65c644-236a-4b13-bcce-ef627d970bfb			2dcc35d2-c643-4af0-8588-73a779c47f39	2012-03-24	Warnings	Exact identifier spl id: fc65c644-236a-4b13-bcce-ef627d970bfb spl set id: 2dcc35d2-c643-4af0-8588-73a779c47f39

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.